Search - tctmd.com

Displaying 1 - 20 of 199

Sort: Relevancy | Date

News Daily News

Meta-analysis: PFO Closure Beats Medical Therapy Alone in Preventing Recurrent Stroke

Yael L. Maxwell

December 22, 2017

News Daily News

Surgical Aortic Valve Repair Effective, Durable in Experienced Hands

Caitlin E. Cox

December 21, 2017

News Daily News

Novel Repositionable TAVR Device Sees Low Pacemaker Rates and Few Leaks

Shelley Wood

December 19, 2017

News Daily News

Isolated Tricuspid Valve Surgery Remains Rare and Risky

Caitlin E. Cox

December 13, 2017

News Daily News

More Headaches: PREMIUM’s Publication Renews Debate Over PFO Closure for Migraine

Yael L. Maxwell

December 01, 2017

News Daily News

New-Generation TAVR Devices Outperform Predecessors in Treating Pure Native AR: Registry

Caitlin E. Cox

November 30, 2017

News Conference News AHA 2017

‘Acceptable Safety’ for LAA Closure Seen in a Real-World, All-Comers Registry

Todd Neale

November 22, 2017

News Daily News

EVAR Shown to IMPROVE Outcomes Over Surgery for Ruptured AAA Patients

L.A. McKeown

November 17, 2017

News Conference News TCT 2017

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

Yael L. Maxwell

November 09, 2017

News Conference News TCT 2017

Experts Debate: Should Cerebral Protection Be Used for All TAVRs?

Todd Neale

November 09, 2017

Presentation Cardiovascular Interventions 2017

TAVR Tips and Tricks: How to Succeed with Challenging Cases

Presenter: Curtiss T. Stinis

November 08, 2017

News Conference News TCT 2017

Early Pilot Study Results Show Symptom Improvement With TMVR

Michael O'Riordan

November 07, 2017

News Conference News TCT 2017

Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used

Todd Neale

November 02, 2017

News Conference News TCT 2017

For ‘Torrential’ Tricuspid Regurgitation, Two New Transcatheter Devices Safe, Effective in Early Results

Yael L. Maxwell

November 02, 2017

Presentation TCT 2017

Adjunctive Pharmacotherapy During and After TAVR: Current Trends, New Studies, and the Case for Short-term (3-6 months) Systemic Anticoagulation

Presenter: Eberhard Grube, James B. Hermiller Jr., Pascal Vranckx

November 01, 2017

Presentation TCT 2017

Complications During and After PFO Closure, Case #3: Arrhythmias

Presenter: John F. Rhodes, Robert J. Sommer

November 01, 2017

Presentation TCT 2017

Complications During and After PFO Closure, Case #2: Chest Pain

Presenter: John F. Rhodes, Robert J. Sommer, Clifford J. Kavinsky

November 01, 2017

Presentation TCT 2017

Complications During and After PFO Closure, Case #1: Pericardial Effusion

Presenter: John F. Rhodes, Robert J. Sommer, Igor F. Palacios

November 01, 2017

Presentation TCT 2017

Case #3: IVC Filter/Obstructed IVC

Presenter: John F. Rhodes, Robert J. Sommer, Anita Asgar

November 01, 2017

Presentation TCT 2017

Challenging Anatomies, Case #2: The 20mm PFO and Atrial Septal Aneurysm

Presenter: John F. Rhodes, Robert J. Sommer, Thomas M. Tu

November 01, 2017

Advertisement

Meta-analysis: PFO Closure Beats Medical Therapy Alone in Preventing Recurrent Stroke

Surgical Aortic Valve Repair Effective, Durable in Experienced Hands

Novel Repositionable TAVR Device Sees Low Pacemaker Rates and Few Leaks

Isolated Tricuspid Valve Surgery Remains Rare and Risky

More Headaches: PREMIUM’s Publication Renews Debate Over PFO Closure for Migraine

New-Generation TAVR Devices Outperform Predecessors in Treating Pure Native AR: Registry

‘Acceptable Safety’ for LAA Closure Seen in a Real-World, All-Comers Registry

EVAR Shown to IMPROVE Outcomes Over Surgery for Ruptured AAA Patients

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

Experts Debate: Should Cerebral Protection Be Used for All TAVRs?

TAVR Tips and Tricks: How to Succeed with Challenging Cases

Early Pilot Study Results Show Symptom Improvement With TMVR

Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used

For ‘Torrential’ Tricuspid Regurgitation, Two New Transcatheter Devices Safe, Effective in Early Results

Adjunctive Pharmacotherapy During and After TAVR: Current Trends, New Studies, and the Case for Short-term (3-6 months) Systemic Anticoagulation

Complications During and After PFO Closure, Case #3: Arrhythmias

Complications During and After PFO Closure, Case #2: Chest Pain

Complications During and After PFO Closure, Case #1: Pericardial Effusion

Case #3: IVC Filter/Obstructed IVC

Challenging Anatomies, Case #2: The 20mm PFO and Atrial Septal Aneurysm

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content